hospitalized COVID-19 patients
[용어속성] Patient
Circulating Ubiquitous RNA, A Highly Predictive and Prognostic Biomarker in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients
순환 유비쿼터스 RNA, 입원한 코로나바이러스 질환 2019(COVID-19) 환자의 고도로 예측하고 예후가 좋은 바이오마커
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
addition
Admission
Biomarker
Biomarkers
Blood
cell lysis
Chain Reaction
circulating
Clinical management
clinical monitoring
clinical outcomes
Clinical severity
coronavirus
coronavirus disease
Coronavirus disease 2019
correlated
COVID-19
COVID-19 patients
Critical
ddPCR
death
develop
disease severity
Diseases
evaluate
Hospitalized
hospitalized COVID-19
hospitalized COVID-19 patient
hospitalized COVID-19 patients
hospitalized patient
Infectious diseases
Invasive mechanical ventilation
lung cell
management
marker
multi-organ failure
organ injury
overall survival
Patient
plasma
polymerase chain
polymerase chain reaction
predict
Predictive
predictive and prognostic biomarkers
prognostic
Prognostic biomarkers
quantification
respiratory
respiratory distress
Respiratory distress syndrome
RNA
RNase P
RNAseP
SARS-CoV-2
SARS-CoV-2 and RNAseP RNAemia
severe acute respiratory syndrome Coronavirus
severe and critical patients
severity
significantly
survival
syndrome
tissue injury
tissue/cell lysis biomarker.
Viral
[DOI] 10.1093/cid/ciab997 PMC 바로가기 [Article Type] Article
[DOI] 10.1093/cid/ciab997 PMC 바로가기 [Article Type] Article
Early prediction of COVID-19 patient survival by targeted plasma multi-omics and machine learning
Research article
Published on
Journal: Molecular & Cellular Proteomics : MCP [Category] COVID19(2023년), SARS, 바이오마커, 변종, 진단, 치료기술,
Journal: Molecular & Cellular Proteomics : MCP [Category] COVID19(2023년), SARS, 바이오마커, 변종, 진단, 치료기술,
[키워드] BSAbovine serum albumin COVID-19
Dickinson and Company
3-nitrophenylhydrazine
AAAamino acid analysis
Accuracy
ACDacid citrate dextrose
acetonitrile
acid citrate dextrose
ACNacetonitrile
Alpha 1-antichymotrypsin
Alpha-1-antichymotrypsin
amino acid analysis
analysis of variance
ANOVAanalysis of variance
APCS
APOA2
APOA4
APOH Beta-2-glycoprotein 1
Apolipoprotein A-IIAPOA4
Apolipoprotein A-IVAPOH Beta-2-glycoprotein 1
area under the curve
AUC
AUCarea under the curve
B2MBeta-2-microglobulin
BDBecton
Becton
Beta-2-microglobulin
BHTbutylated hydroxyl toluene
bovine serum albumin COVID-19
BQC19
building
butylated hydroxyl toluene
C-reactive protein
C1RLComplement C1r subcomponent-like protein
C2Complement C2
C3Complement C3
C4AComplement C4
C4b-binding protein alpha chain
C4BPAC4b-binding protein alpha chain
C5Complement C5
C7Complement C7
C9Complement C9
CAMPCathelicidin antimicrobial peptide
capillary zone electrophoresis
Carboxypeptidase B2
Cathelicidin antimicrobial peptide
CFBComplement factor B
CFHComplement factor H
Clinical Proteomic Tumor Analysis Consortium
Coagulation factor XIII A chain
Complement C1r subcomponent-like protein
Complement C2
Complement C3
Complement C4
Complement C5
Complement C7
Complement C9
Complement factor B
Complement factor H
Concentration
concentrations
Control
COVID-19 hospitalization
COVID-19 patient
CPB2Carboxypeptidase B2
CPTACClinical Proteomic Tumor Analysis Consortium
CRPC-reactive protein
CST3Cystatin-C
Cystatin-C
CZEcapillary zone electrophoresis
disease severity
dithiothreitol
DTTdithiothreitol
ECMOextracorporeal membrane oxygenation
extracorporeal membrane oxygenation
F13A1Coagulation factor XIII A chain
FAFormic acid
false discovery rate
FDRfalse discovery rate
FGAFibrinogen alpha chain
FGBFibrinogen beta chain
FGGFibrinogen gamma chain
Fibrinogen alpha chain
Fibrinogen beta chain
Fibrinogen gamma chain
FIVE
Formic acid
Gelsolin
Gene name /Protein nameAPCS
globe
GSNGelsolin
haptoglobin
Healthcare system
Heparin cofactor 2
Hospitalization
hospitalized COVID-19 patients
HPhaptoglobin
IAAiodoacetamide
ICUIntensive Care Unit
IGFALSInsulin-like growth factor-binding protein complex acid labile subunit
Insulin-like growth factor-binding protein complex acid labile subunit
intensive care unit
Inter-alpha-trypsin inhibitor heavy chain H2
Inter-alpha-trypsin inhibitor heavy chain H4
iodoacetamide
ITIH2Inter-alpha-trypsin inhibitor heavy chain H2
ITIH4Inter-alpha-trypsin inhibitor heavy chain H4
K3EDTAtripotassium ethylenediaminetetraacetic acid
L-(tosylamido-2-phenyl) ethyl chloromethyl ketoneTrisHCl
LC-MSliquid chromatography-mass spectrometry
LC/MRM-MSliquid chromatography/multiple reaction monitoring mass spectrometry
Leucine-rich alpha-2-glycoprotein
liquid chromatography-mass spectrometry
liquid chromatography/multiple reaction monitoring mass spectrometry
LLOQLower Limit of Quantitation
Lower Limit of Quantitation
LRG1Leucine-rich alpha-2-glycoprotein
lysoPClysophosphatidylcholine
lysophosphatidylcholine
MALDImatrix assisted laser desorption ionization
mass spectrometry
matrix assisted laser desorption ionization
MeOHmethanol
metabolite
methanol
Mortality
MSmass spectrometry
N-acetylmuramoyl-L-alanine amidase
Neuropilin-2
Non-survivors
NPH3-nitrophenylhydrazine
NRP2Neuropilin-2
patient survival
PBSPhosphatase buffered saline
PCAprincipal component analysis
PCRpolymerase chain reaction
PGLYRP2N-acetylmuramoyl-L-alanine amidase
phenylisothiocyanate
Phosphatase buffered saline
PITCphenylisothiocyanate
plasma
polymerase chain reaction
post-translational modification
predict
Predictive
PRG4Proteoglycan 4
principal component analysis
PROS1Vitamin K-dependent protein S
Protein
Proteoglycan 4
PTMpost-translational modification
QCquality control
Quality control
reversed phase ultrahigh performance liquid chromatography
robust
RP-UHPLCreversed phase ultrahigh performance liquid chromatography
SAA2Serum amyloid A-1 and A-2 proteins
SAA4Serum amyloid A-4 protein
SARS-CoV-2SIS
Scientific and Cultural Organization
Sequential Organ Failure AssessmentSPE
SERPINA1Alpha-1-antichymotrypsin
SERPINA3Alpha 1-antichymotrypsin
SERPIND1Heparin cofactor 2
Serum amyloid A-1 and A-2 proteins
Serum amyloid A-4 protein
Serum amyloid P-componentAPOA2
significant difference
SIS
SOFA
solid-phase extractionSVM
SPE
stable-isotope labeled internal standardSOFA
Stratification
Support Vector MachineTPCK
survival
survivor
SVM
The Universal Protein Resource
TPCK
Transthyretin
Treatment
tripotassium ethylenediaminetetraacetic acid
Tris (hydroxymethyl) aminomethane hydrochlorideUNESCO
TrisHCl
TTRTransthyretin
UNESCO
UniProtThe Universal Protein Resource
unique
United Nations EducationalScientific and Cultural Organization
Vascular cell adhesion protein 1
VCAM1Vascular cell adhesion protein 1
Vitamin K-dependent protein S
[DOI] 10.1016/j.mcpro.2022.100277 [Article Type] Research article
[DOI] 10.1016/j.mcpro.2022.100277 [Article Type] Research article
Increased plasma level of soluble P-selectin in non-hospitalized COVID-19 convalescent donors
입원하지 않은 COVID-19 회복기 기증자에서 가용성 P-셀렉틴의 혈장 수준 증가
Article
[키워드] Activation
acute disease
baseline characteristics
Biomarker
Blood
blood donor
Blood donors
blood sampling
CD62P
Characteristics
Coagulation
Coagulation system
comparable
Control
controls
convalescent
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
COVID-19 convalescent donor
COVID-19 convalescent donors
COVID-19 diagnosis
COVID-19 symptom
COVID-19 symptoms
decrease
demonstrated
disease
disease severity
Donor
donors
ELISA
endothelial
evaluated
Factor
flow cytometry
hospitalized COVID-19 patient
hospitalized COVID-19 patients
implication
in vitro
Increased
lead
longitudinal study
marker
Moderate COVID-19
MOST
non-infected
P-selectin
Participation
phenotype
plasma
plasma concentration
Plasma marker
plasma samples
Platelet
platelet activation
Platelet function
procoagulant
questionnaire
recruited
reported
Research
SARS-CoV-2
SARS-COV-2 infection
significantly higher
Soluble P-selectin.
study groups
suffered
systemic disease
Transmission
Trial
Vascular
was determined
was measured
was obtained
was performed
were recorded
[DOI] 10.1016/j.thromres.2022.06.014 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.thromres.2022.06.014 PMC 바로가기 [Article Type] Article
SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19
SARS-CoV-2 감염은 COVID-19의 초기 중등도 단계에서 가용성 혈소판 활성화 마커 및 PAI-1을 유도합니다
Article
[키워드] activated
activated partial thromboplastin time
activation of platelet
activation of platelets
Analysis
aPTT
CD40 ligand
Coagulation
coagulation dysfunction
coagulation factor
Coagulation factors
Coagulation system
coagulation test
coagulation tests
Comorbidity
correlated
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 severity
D-dimer
dysfunction
dysregulated
elevated
Factor
fibrinogen
flow cytometry
FXIII
help
hospitalized COVID-19 patient
hospitalized COVID-19 patients
induce
inhibitor
intensive care
limit
marker
moderate
Moderate COVID-19
molecular
Multiplex assay
P-selectin
partial thromboplastin time
Pathogenesis
pathogenesis of COVID-19
pathway
performed
plasma
plasminogen
Platelet
platelet activation
Platelets
Pneumonia
progression
prothrombin
Prothrombin time
recruited
reduction in
required
SARS-COV-2 infection
severe cases
severe COVID-19
severe patients
severity
significantly
Stage
TFPI
the disease
Thromboembolism
THROMBOPLASTIN
Thromboprophylaxis
tissue
Tissue Factor
tissue factor pathway inhibitor
tissue plasminogen activator
[DOI] 10.1111/ijlh.13829 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/ijlh.13829 PMC 바로가기 [Article Type] Article
Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels
입원한 코로나19 환자에서 프로칼시토닌의 특성과 프로칼시토닌 수치로 계층화된 항생제 사용의 임상적 결과
Article
[키워드] antibiotic
antibiotic use
Antibiotics
Bacterial
bacterial co-infection
baseline characteristics
Characteristics
clinical
Clinical outcome
clinical outcomes
Cohort
COVID-19
COVID-19 patient
COVID-19 severity
Critically ill
Cutoff
disease
do not intubate
do not resuscitate
elevated
examined
excluded
Factor
group
hospital
hospitalized COVID-19 patient
hospitalized COVID-19 patients
ICU
ICU patient
Infection
intensive care
mechanical ventilation
median
microbiologically
non-critically ill patient
non-critically ill patients
non-ICU
NPV
oxygen
Oxygen requirement
Patient
PCT
performed
PPV
pro-calcitonin
procalcitonin
procalcitonin level
renal
renal disease
retrospective review
significantly
significantly higher
status
stratified
Tocilizumab
use of antibiotics
utility
[DOI] 10.1007/s11739-022-02955-5 PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s11739-022-02955-5 PMC 바로가기 [Article Type] Article
Multiple Types of Taste Disorders among Patients with COVID-19
Observational Study
[키워드] affected
analyzed
bitter taste
Characteristics
Clinical course
collected
combined use
component
coronavirus disease
COVID-19
COVID-19 patient
COVID-19 patients
develop
disorder
disorders
enrolled
Frequency
hospitalized COVID-19 patients
hypersensitivity
incidence
Infection
investigated
Laboratory
medical records
Multiple
objective
Patient
patients
radiological
reported
required
Result
retrospective
salty
SARS-CoV-2
single-center
sweet
Symptom
Taste
taste dysfunction
taste-impaired.
Type
with COVID-19
[DOI] 10.2169/internalmedicine.9065-21 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.2169/internalmedicine.9065-21 PMC 바로가기 [Article Type] Observational Study
Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study
정맥 또는 동맥 혈전증이 있거나 없는 COVID-19 감염의 항인지질 항체 및 비타민 D 결핍: 파일럿 사례 대조 연구
Article
[키워드] antibody
Anticoagulant
anticoagulation
antiphospholipid antibody
Autoimmune disorders
case-control study
Chronic kidney disease
Control
COVID-19
COVID-19 infection
COVID-19 patient
deficiency
Effect
End-stage renal disease
enrolled
evaluate
Future
hospitalized COVID-19 patient
hospitalized COVID-19 patients
in both groups
malignancy
measure
mechanisms
Myocardial infarction
Patient
positive
reducing
Sex
significantly more
stroke
syndrome
therapy
Thromboembolic event
Thromboembolic events
Thromboembolism
thrombosis
venous
vitamin D deficiency
vitamin D level
were excluded
were measured
[DOI] 10.1371/journal.pone.0269466 PMC 바로가기 [Article Type] Article
[DOI] 10.1371/journal.pone.0269466 PMC 바로가기 [Article Type] Article
Effects of mental health interventions among people hospitalized with COVID-19 infection: A systematic review of randomized controlled trials
COVID-19 감염으로 입원한 사람들의 정신 건강 중재 효과: 무작위 대조 시험의 체계적인 검토
Review
[키워드] Accuracy
breathing exercises
China
cognitive
Combination
conducted
confidence
controlled trials
COVID-19
database
domains
Effect
Effects
Efficacy
evaluated
Frequency
Health care
heterogeneity
Hospitalized
hospitalized COVID-19 patient
hospitalized COVID-19 patients
imagery
information
Intervention
interventions
Iran
mental health
mental health interventions
physical
poor quality
PROSPERO
Psychological intervention
Psychological interventions
Randomized controlled trial
Randomized controlled trials
recommendation
Registered
Result
risk of bia
searched
Symptoms
systematic review
tested
Trial
trials
Turkey
with COVID-19
[DOI] 10.1016/j.genhosppsych.2022.04.002 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.genhosppsych.2022.04.002 PMC 바로가기 [Article Type] Review
Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials
Interleukin-6 억제제는 코로나바이러스 질병-2019의 사망률을 감소시킵니다: 무작위 대조 시험의 개별 환자 데이터 메타 분석
Meta-Analysis
[키워드] 95%CI
age
Analysis
confidence
confidence interval
coronavirus
COVID-19
COVID-19 patients
data extraction
database
death
discharge
discharge rate
Efficacy
eligible
hazard
hazard ratio
hospitalized COVID-19 patient
hospitalized COVID-19 patients
IL-6
IL-6 inhibitor
IL-6 inhibitors
individual
inhibitor
inhibitors
Inteleukin-6
intubation
Kaplan-Meier curve
meta-analyses
Meta-analysis
outcome
Patient
patient data
patients
Randomized control trials
Randomized controlled trial
randomized trial
randomized trials
Ratio
RCTs
reduce
reduce mortality
risk
risk of death
significantly
SOC.
Standard of care
synthesis
systematic review
the mean
the MEDLINE
Trial
two group
two groups
was performed
[DOI] 10.1016/j.ejim.2022.04.004 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1016/j.ejim.2022.04.004 PMC 바로가기 [Article Type] Meta-Analysis